Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia
KMT2A (MLL)-rearranged acute lymphoblastic leukemia (ALL) is one of the most severe forms of leukemia that corresponds with high mortality, especially in relapsed or refractory cases. ALL affects both adults and children, thereby necessitating the need for treatment options that provide higher effi...
Saved in:
| Main Authors: | Khushbakht Baloch, Muniba Shoaib, Mishal Fatima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ziauddin University
2025-04-01
|
| Series: | Pakistan Journal of Medicine and Dentistry |
| Subjects: | |
| Online Access: | https://ojs.zu.edu.pk/pjmd/article/view/3582 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of Baseline Clinical Characteristics as Risk Factors for Pneumonia in Children with Acute Lymphoblastic Leukemia (ALL)
by: Prachi Singh, et al.
Published: (2025-03-01) -
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
by: Luisa Brock, et al.
Published: (2025-05-01) -
Does distance to the hospital affect the course of treatment and follow-up for children with Acute Lymphoblastic Leukemia?
by: Cecilie Bjerregaard Brix, et al.
Published: (2025-02-01) -
Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India
by: Ashis Mukhopadhyay, et al.
Published: (2013-01-01) -
Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
by: NA Batmanova, et al.
Published: (2017-07-01)